Condition

Endocrine System Diseases

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 65 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials65

Recruiting8

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)NCT07699380 · 2026-09-01

Telehealth Music Therapy for Adults With Endocrine Disorder and DepressionNCT07413874 · 2026-07-16

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingNCT07613307 · 2026-07-15

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult CareNCT05910840 · 2024-10-07

The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 DiabetesNCT07348432 · 2024-07-29

Implementation of Support in the Care of Adults Living With Type 1 DiabetesNCT06069583 · 2024-05-05

Rare and Atypical Diabetes NetworkNCT05544266 · 2020-09-30

RT-CGM in Young Adults at Risk of DKANCT04039763 · 2020-09-03

Financial Navigation and Peer Support to Improve Diabetes OutcomesNCT06619834 · 2025-02-11

Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DMNCT06529965 · 2024-10-09

ACTIVE_NOT_RECRUITING

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 DiabetesNCT06557317 · 2024-08-01

Group Education Trial to Improve Transition for Parents of Adolescents With T1DNCT05445284 · 2023-10-10

Online Diabetes Clinic Support ProgramNCT06767865 · 2023-10-01

Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose MonitoringNCT04972955 · 2023-07-04

ACTIVE_NOT_RECRUITING

Analysis of Volatile Organic Compounds in Patients With Type 1 Diabetes in Induced Hypoglycaemia With a Breath AnalyserNCT05933616 · 2023-04-20

Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in ChinaNCT05726461 · 2023-02-11

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesNCT05691712 · 2023-02-05

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1DNCT05565248 · 2023-01-20

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on MetforminNCT05505994 · 2022-09-28

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or BothNCT05260021 · 2022-04-13

Digital Foot Self-Management Program for Older-DiabetesNCT05272670 · 2022-02-15

An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1DNCT05210530 · 2022-01-24

Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIITNCT05084079 · 2021-11-01

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II DiabetesNCT05014204 · 2021-10-29

Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT)NCT04902378 · 2021-06-15

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 DiabetesNCT04880291 · 2021-05-05

A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesNCT04809220 · 2021-04-13

Trabecular Bone Score in Multiple SclerosisNCT05811689 · 2021-02-14

Integration of Health Coaching and Diabetes Education in Type 2 Diabetes Mellitus Management at Primary Health CareNCT05090488 · 2020-12-14

A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mgNCT04653779 · 2020-12-01

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19NCT04371978 · 2020-10-01

A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseNCT04387448 · 2020-07-28

Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and DonorsNCT04351945 · 2020-05-20

Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With HypertriglyceridaemiaNCT04700436 · 2020-01-03

NEW ONSET ENDOCRINE DYSFUNCTION AFTER ACUTE PANCREATITISNCT04513197 · 2019-03-01

Low-Carbohydrate Dietary Pattern on Glycemic Outcomes TrialNCT03675360 · 2018-09-25

Azithromycin Insulin Diet Intervention Trial in Type 1 DiabetesNCT03682640 · 2018-09-01

Soluble Epoxide Hydrolase Inhibition and Insulin ResistanceNCT03486223 · 2018-05-17

Investigating Genetic Risk for Type 1 DiabetesNCT03503747 · 2018-04-25

Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator TrialNCT03342495 · 2018-02-06

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 DiabetesNCT03345004 · 2017-12-20

Day and Night Closed-loop in Young People With Type 1 DiabetesNCT02925299 · 2017-05-12

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsNCT03037385 · 2017-03-17

Home Testing of Day and Night Closed Loop With Pump Suspend FeatureNCT02523131 · 2016-05-01

Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 DiabetesNCT03199638 · 2016-04-01

Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in HumansNCT02710370 · 2016-02-01

ACTIVE_NOT_RECRUITING

Closing the Loop 24/7 in Adolescents With Type 1 DiabetesNCT01873066 · 2014-08-28

Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference TechniqueNCT02102737 · 2014-05-13

Effect of Amino Acids and Sugar Alcohols on Satiation Peptides and Activation of Specific Brain RegionsNCT02823249 · 2014-05-01

Effect of Amino Acids and Sugar Alcohols on Gastric Emptying and Release of Satiation Peptides in HumansNCT02563847 · 2014-05-01

Automated Closed-loop in Children and Adolescents With Type 1 DiabetesNCT02129868 · 2014-04-01

Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes MellitusNCT02644759 · 2014-02-01

Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home SettingNCT01778348 · 2013-12-01

Pharmacokinetics Study of Gamma-aminobutyric AcidNCT01917760 · 2013-07-01

Oral Glucose Stimulation in Normal-weight and Obese VolunteersNCT01875575 · 2013-02-01

Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH StudyNCT01435603 · 2011-08-01

Diabetic Treatment AdherenceNCT01318564 · 2011-03-01

Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult FemalesNCT01301456 · 2011-03-01

Aldosterone and the Metabolic SyndromeNCT01103245 · 2010-03-01

Effect of Fish Oil (Omega-3 Fatty Acids) on ArteriesNCT00935766 · 2009-09-01

Common interventions

Leading sponsors

University Hospital, Basel, Switzerland 5 Eli Lilly and Company 4 University of Cambridge 4 CRISPR Therapeutics AG 2 Goldfinch Bio, Inc. 2 McGill University 2 University of Calgary 2 Vanderbilt University Medical Center 2 Anne-Sophie Brazeau 1 Appalachian State University 1 Asian Institute of Gastroenterology, India 1 Cornell University 1 Daewoong Pharmaceutical Co. LTD. 1 Denver Health and Hospital Authority 1 Diamyd Medical AB 1

Trial status mix

COMPLETED39

UNKNOWN11

RECRUITING8

TERMINATED4

ACTIVE_NOT_RECRUITING3

Phase mix

NA27

PHASE210

PHASE19

PHASE37

PHASE43

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.